SCHEMBL4173142

SCHEMBL4173142

N#C/C(=C/c1ccc(O)cc1O)S(=O)(=O)Cc1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.44
MIF P14174 1/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
NSD2 O96028 1/20 0.41
IDE P14735 1/20 0.41
MAPT P10636 3/20 0.40
EGFR P00533 3/20 0.37
MAOB P27338 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
POLA1 P09884 1/20 0.37
LCK P06239 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4173138 1.00 HSP90AA1 (0.44) HSP90AA1MIFMEN1KMT2ANSD2
SCHEMBL4173145 1.00 HSP90AA1 (0.44) HSP90AA1MIFMEN1KMT2ANSD2
SCHEMBL4178400 0.88 MIF (0.43) MIFMAPTEGFRMAOBLCK
SCHEMBL4178406 0.88 MIF (0.43) MIFMAPTEGFRMAOBLCK
SCHEMBL4178397 0.88 MIF (0.43) MIFMAPTEGFRMAOBLCK
SCHEMBL4175188 0.86 ERCC1 (0.45) HSP90AA1MIFMEN1KMT2AMAPT
SCHEMBL4175195 0.86 ERCC1 (0.45) HSP90AA1MIFMEN1KMT2AMAPT
SCHEMBL4175198 0.86 ERCC1 (0.45) HSP90AA1MIFMEN1KMT2AMAPT
SCHEMBL4188837 0.85 MEN1 (0.43) HSP90AA1MEN1KMT2ANSD2IDE
SCHEMBL4188848 0.85 MEN1 (0.43) HSP90AA1MEN1KMT2ANSD2IDE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 HSP90AA1 1476/4885MIF 3495/4885MEN1 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.